abstract |
The present inventors have surprisingly found that the expression of PD-L1 can be modulated by binding of a modulator to CD11b on immune cells and/or other cells, whereby treatment and/or prevention is associated with immunosuppression and/or immune exhaustion Diseases such as chronic infection, sepsis, immunodeficiency in cancer, and immune aging in aging. |